menu
    • menu

    Company profile for Aulos

    NEW Drugs in Dev: 1
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Aulos was created by ATP, a leading life science venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies, to initially develop unique IL‑2 targeting antibodies that it believes have the potential to become best-in-class treatments for s...
    Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics. Aulos was created by ATP, a leading life science venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies, to initially develop unique IL‑2 targeting antibodies that it believes have the potential to become best-in-class treatments for solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AulosUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main Street Floor 12 Cambridge, Ma 02142
    Telephone
    Telephone
    +1 (617) 294-6790
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aulosbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aulos Reports Positive Phase 2 Imneskibart Data at ASCO 2026
    Aulos Reports Positive Phase 2 Imneskibart Data at ASCO 2026

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260521719775/en/Aulos-Bioscience-Reports-Positive-Phase-2-Data-for-Imneskibart-in-Doublet-Checkpoint-Inhibitor-Refractory-Metastatic-Melanoma-at-2026-ASCO-Annual-Meeting

    BUSINESSWIRE
    21 May 2026
    Share Share
    Aulos Bioscience to Present Imneskibart Melanoma Data at ASCO
    Aulos Bioscience to Present Imneskibart Melanoma Data at ASCO

    21 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260421905935/en/Aulos-Bioscience-Announces-Presentation-of-Promising-Phase-12-Data-for-Imneskibart-in-Melanoma-at-2026-ASCO-Annual-Meeting

    BUSINESSWIRE
    21 Apr 2026
    Share Share
    Aulos Bioscience's Imneskibart Shows Clinical Activity
    Aulos Bioscience's Imneskibart Shows Clinical Activity

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107006073/en/New-Phase-2-Data-for-Aulos-Biosciences-Imneskibart-Reveal-Clinical-Activity-in-Melanoma-and-Non-Small-Cell-Lung-Cancer

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Aulos Bioscience To Present Phase 2 Imneskibart (AU-007) Data
    Aulos Bioscience To Present Phase 2 Imneskibart (AU-007) Data

    03 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251003952038/en/Aulos-Bioscience-to-Present-Updated-Phase-2-Data-for-Imneskibart-AU-007-in-Melanoma-and-Non-Small-Cell-Lung-Cancer-at-40th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting

    BUSINESSWIRE
    03 Oct 2025
    Share Share
    Aulos Bioscience Presents New Phase 2 Data for AU-007 at AACR 2025
    Aulos Bioscience Presents New Phase 2 Data for AU-007 at AACR 2025

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429960244/en/Aulos-Bioscience-Presents-New-Phase-2-Data-for-AU-007-Demonstrating-Continued-Strong-Anti-Tumor-Activity-in-Advanced-Cancers-at-AACR-Annual-Meeting

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    Aulos Bioscience doses first patient in Phase 2 evaluating AU-007
    Aulos Bioscience doses first patient in Phase 2 evaluating AU-007

    14 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250414240962/en/Aulos-Bioscience-Doses-First-Patient-in-Phase-2-Cohort-Evaluating-AU-007-in-Combination-With-Nivolumab-for-Second-Line-Treatment-of-Melanoma

    BUSINESSWIRE
    14 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search